Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
- Status
- COMPLETED
- Phase
- PHASE1
Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection
- Status
- COMPLETED
- Phase
- PHASE2
Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
- Status
- COMPLETED
- Phase
- N/A
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin
- Status
- COMPLETED
- Phase
- PHASE4
Selonsertib in Adults With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples
- Status
- COMPLETED
- Phase
- N/A
Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
- Status
- COMPLETED
- Phase
- PHASE1
Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3